Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CEO Sells $6,844,836.80 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 84,640 shares of Tempus AI stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $80.87, for a total transaction of $6,844,836.80. Following the transaction, the chief executive officer now directly owns 4,964,820 shares in the company, valued at approximately $401,504,993.40. This trade represents a 1.68 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Tempus AI Trading Down 11.2 %

Shares of NASDAQ:TEM opened at $68.09 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The company has a fifty day simple moving average of $50.29 and a 200 day simple moving average of $51.72. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45.

Analyst Ratings Changes

TEM has been the topic of a number of recent research reports. William Blair cut shares of Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Guggenheim initiated coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. TD Cowen reaffirmed a “buy” rating and set a $74.00 price target (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 price target on shares of Tempus AI in a research report on Tuesday, January 14th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $58.55.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. Operose Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter worth $25,000. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the third quarter worth $30,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter worth $34,000. Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter worth $49,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.